Analysts expect that UnitedHealth Group Inc (NYSE:UNH) will post $60.61 billion in sales for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for UnitedHealth Group’s earnings, with the highest sales estimate coming in at $61.21 billion and the lowest estimate coming in at $59.92 billion. UnitedHealth Group reported sales of $56.09 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 8.1%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, July 16th.

On average, analysts expect that UnitedHealth Group will report full-year sales of $243.86 billion for the current financial year, with estimates ranging from $241.80 billion to $244.97 billion. For the next fiscal year, analysts expect that the company will post sales of $262.39 billion, with estimates ranging from $257.91 billion to $265.56 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that follow UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The firm had revenue of $60.30 billion for the quarter, compared to analyst estimates of $59.72 billion. During the same quarter in the prior year, the company posted $3.04 earnings per share. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis.

A number of brokerages recently weighed in on UNH. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 11th. Citigroup upgraded UnitedHealth Group from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $247.00 to $280.00 in a research report on Friday, May 10th. UBS Group started coverage on UnitedHealth Group in a research report on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 target price on the stock. ValuEngine downgraded UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Thursday, April 18th. Finally, Barclays reduced their price objective on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 17th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $290.47.

In related news, Director Richard T. Burke sold 5,000 shares of the stock in a transaction dated Tuesday, March 19th. The stock was sold at an average price of $257.32, for a total transaction of $1,286,600.00. Following the transaction, the director now directly owns 182,454 shares in the company, valued at $46,949,063.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David S. Wichmann bought 20,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 3rd. The shares were acquired at an average price of $231.79 per share, for a total transaction of $4,635,800.00. Following the completion of the transaction, the chief executive officer now directly owns 904,367 shares of the company’s stock, valued at approximately $209,623,226.93. The disclosure for this purchase can be found here. Insiders have sold 27,930 shares of company stock worth $6,746,683 over the last quarter. 0.87% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Oregon Public Employees Retirement Fund lifted its position in UnitedHealth Group by 50,446.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock worth $214,000 after buying an additional 53,244,249 shares during the period. Norges Bank purchased a new position in UnitedHealth Group during the fourth quarter worth about $2,343,175,000. BlackRock Inc. lifted its position in UnitedHealth Group by 3.1% during the fourth quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock worth $17,396,391,000 after buying an additional 2,123,417 shares during the period. Janus Henderson Group PLC lifted its position in UnitedHealth Group by 38.4% during the first quarter. Janus Henderson Group PLC now owns 5,525,999 shares of the healthcare conglomerate’s stock worth $1,366,354,000 after buying an additional 1,532,738 shares during the period. Finally, FMR LLC lifted its position in UnitedHealth Group by 1.9% during the fourth quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock worth $16,063,258,000 after buying an additional 1,232,189 shares during the period. Hedge funds and other institutional investors own 87.29% of the company’s stock.

Shares of UNH stock opened at $236.08 on Thursday. UnitedHealth Group has a 1-year low of $208.07 and a 1-year high of $287.94. The firm has a market cap of $227.65 billion, a P/E ratio of 18.33, a price-to-earnings-growth ratio of 1.28 and a beta of 0.74. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.63.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Cost of Goods Sold (COGS)

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.